DWA Healthcare Momentum Invesco ETF (PTH)

$147.99 1.90 (1.27%)

16:15 EST PTH Stock Quote Delayed 30 Minutes

Volume:

Previous Close -

Market Cap 406.98M

PE Ratio -

EPS -

Volume (Avg. Vol.) 29,738

Day's Range 147.29 - 149.28

52-Week Range 69.41 - 153.15

Dividend & Yield N/A (N/A)

PTH Stock Predictions, Articles, and DWA Healthcare Momentum Invesco ETF News

From InvestorPlace
From the Web

4 Interesting ETFs for More Adventurous Investors

By Joel Baglole Nov 16, 2020

Today's exchange-traded funds are diverse investment vehicles that can offer big returns to investors. Here are four ETFs to consider.

7 Healthcare ETFs Which Should Continue Growing Into 2021

By Chris Markoch Jul 6, 2020

Between the novel coronavirus and an election year, these healthcare ETFs appear poised to post strong growth into 2021.

The 7 Best Healthcare ETFs for a Sector Rebound

By Todd Shriber, InvestorPlace Contributor Mar 5, 2019

While traditional healthcare ETFs are not delivering jaw-dropping performances in the first quarter, there are some encouraging signs.

3 Healthcare ETFs That Will Bounce Back in 2017

By Todd Shriber, InvestorPlace Contributor Dec 13, 2016

2016 was a bad year for healthcare ETFs, but with the presidential election behind us, ETFs like IHI, CNCR and PTH could see a surge.

3 Health Care ETFs Where Components Are Enduring Downgrades

From Benzinga Sep 25, 2020

After setting scintillating paces earlier this thanks to the race to develop a coronavirus vaccine, some health care exchange-traded funds are languishing. What Happened: It could...

3 ETFs To Play Gilead's $21B Immunomedics Takeover

From Benzinga Sep 14, 2020

Biotechnology mergers and acquisitions appear to be back in a big way with news that Gilead Sciences (NASDAQ: GILD) is acquiring Immunomedics (NASDAQ: IMMU) for $21 billion. That...

5 ETFs Jump After Three-Day Rout: Will The Rally Last?

From Talk Markets Sep 10, 2020

Here are the ETFs that were at the forefront of the market rebound on Sep 9 and will continue to do so if market sentiments remain positive.

Will Novavax ETFs Gain On Coronavirus Vaccine Progress?

From Talk Markets Sep 5, 2020

Novavax (NVAX) is a formidable name in the list of companies who are working on a vaccine. The company’s shares have gained 2487.4% this year. Let’s look at ETFs with the highest exposure to Novarax that can gain on the positive development,